Graves disease

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Graves disease.php on line 2
Graves disease

LE WE PMID CA

Graves disease

334

Basedow Thyreoiditis

Autoantibodies Anti Flavoprotein subunit succinat dehydrogenase

Autoantibodies Anti IGF1R

Eye (Diseases)

Eye and orbita (Neoplasia)

Fibrosis

Graves disease

IGF1

Moyamoya s disease

Thyroid (Diseases)

1997 1	Pediatric Graves' disease: therapeutic options and experience with radioiodine at the University of Mississippi Medical Center. [9347812] South Med J 90(10): 1017-22 (1997)
2010 2	Current and emerging treatment options for Graves' hyperthyroidism. [20169034] Ther Clin Risk Manag 6(): 29-40 (2010)
2002 3	Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. [11876739] Clin Exp Immunol 127(2): 193-8 (2002)
2003 4	Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease. [12727937] J Clin Endocrinol Metab 88(5): 1939-46 (2003)
2003 5	How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism? [12629070] J Clin Endocrinol Metab 88(3): 975-7 (2003)
2001 6	Pathogenesis of Graves' ophthalmopathy--current understanding. [11157999] J Clin Endocrinol Metab 86(2): 501-3 (2001)
1998 7	Thyroid controversy--stimulating antibodies. [9814446] J Clin Endocrinol Metab 83(11): 3777-85 (1998)
1998 8	Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment. [9814445] J Clin Endocrinol Metab 83(11): 3767-76 (1998)
1993 9	The enigma of Graves' ophthalmopathy. [8337870] West J Med 158(6): 633-5 (1993)
1993 10	Graves' ophthalmopathy. [8337853] West J Med 158(6): 591-5 (1993)
1984 11	Graves' eye disease: orbital compliance and other physical measurements. [6398935] Trans Am Ophthalmol Soc 82(-): 492-598 (1984)
2003 12	Ophthalmological evaluation in thyroid-associated ophthalmopathy. [14510789] Acta Ophthalmol Scand 81(5): 437-48 (2003)
1999 13	Significance of serum antibodies reactive with flavoprotein subunit of succinate dehydrogenase in thyroid associated orbitopathy. [10216063] Br J Ophthalmol 83(5): 605-8 (1999)
1996 14	Thyroid eye disease. [8976707] Br J Ophthalmol 80(10): 922-6 (1996)
2003 15	Diagnosis and management of Graves' disease. [12615754] CMAJ 168(5): 575-85 (2003)
2006 16	Rapidly progressive fatal bihemispheric infarction secondary to Moyamoya syndrome in association with Graves thyrotoxicosis. [16552009] AJNR Am J Neuroradiol 27(3): 643-7 (2006)
2005 17	Editorial: glucocorticoids for Graves' ophthalmopathy: how and when. [16148347] J Clin Endocrinol Metab 90(9): 5497-9 (2005)
2004 18	Orbital radiotherapy for Graves' ophthalmopathy. [14715819] J Clin Endocrinol Metab 89(1): 13-4 (2004)
2010 19	The thyrocyte-fibrocyte link: closing the loop in the pathogenesis of Graves' disease? [20056811] J Clin Endocrinol Metab 95(1): 62-5 (2010)
2009 20	Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis. [19491222] J Clin Endocrinol Metab 94(8): 2708-16 (2009)
2011 21	Drug discontinuation after treatment with minimum maintenance dose of an antithyroid drug in Graves' disease: a retrospective study on effects of treatment duration with minimum maintenance dose on lasting remission. [21206137] Endocr J 58(2): 95-100 (2011)
2008 22	Rituximab in Graves' disease. [18708435] Eur J Endocrinol 159(5): 515-6 (2008)
2007 23	Psychological implications of Graves' orbitopathy. [17656589] Eur J Endocrinol 157(2): 127-31 (2007)
2005 24	A systematic review of drug therapy for Graves' hyperthyroidism. [16189168] Eur J Endocrinol 153(4): 489-98 (2005)
2008 25	Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. [18299459] Eur J Endocrinol 158(3): 273-85 (2008)
2009 26	Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. [18849306] Eur J Endocrinol 160(1): 1-8 (2009)
2003 27	Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. [14671007] Endocr Rev 24(6): 802-35 (2003)
2010 28	Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases? [20392809] Pharmacol Rev 62(2): 199-236 (2010)
2009 29	Update on the medical treatment of Graves' ophthalmopathy. [20360911] Int J Gen Med 2(-): 263-9 (2009)
2008 30	The eye and thyroid disease. [18854695] Curr Opin Ophthalmol 19(6): 499-506 (2008)
2010 31	Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. [19818507] Ophthalmology 117(1): 133-139.e2 (2010)
2010 32	Pediatric Graves' disease: controversies in management. [20924158] Horm Res Paediatr 74(5): 305-11 (2010)
2008 33	Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. [18788919] Thyroid 18(9): 983-8 (2008)
2008 34	Immune mechanisms in thyroid eye disease. [18752427] Thyroid 18(9): 959-65 (2008)
2008 35	Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. [18713026] Thyroid 18(9): 953-8 (2008)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Graves disease.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Graves disease.php on line 92